GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » Shiller PE Ratio

Nipro (NPRRF) Shiller PE Ratio : (As of May. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Nipro Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nipro Shiller PE Ratio Historical Data

The historical data trend for Nipro's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Shiller PE Ratio Chart

Nipro Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.47 28.51 26.43 18.45 19.16

Nipro Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.02 19.16 18.75 20.87 18.98

Competitive Comparison of Nipro's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Nipro's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Shiller PE Ratio falls into.



Nipro Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nipro's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Nipro's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/106.8000*106.8000
=0.000

Current CPI (Dec. 2023) = 106.8000.

Nipro Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.098 95.700 -0.109
201406 0.073 98.000 0.080
201409 0.260 98.500 0.282
201412 0.493 97.900 0.538
201503 -0.122 97.900 -0.133
201506 0.186 98.400 0.202
201509 0.085 98.500 0.092
201512 0.403 98.100 0.439
201603 0.300 97.900 0.327
201606 0.011 98.100 0.012
201609 0.143 98.000 0.156
201612 0.518 98.400 0.562
201703 -0.141 98.100 -0.154
201706 0.209 98.500 0.227
201709 0.199 98.800 0.215
201712 0.268 99.400 0.288
201803 -0.113 99.200 -0.122
201806 0.232 99.200 0.250
201809 0.143 99.900 0.153
201812 0.111 99.700 0.119
201903 0.114 99.700 0.122
201906 0.143 99.800 0.153
201909 0.160 100.100 0.171
201912 0.253 100.500 0.269
202003 -1.318 100.300 -1.403
202006 0.156 99.900 0.167
202009 0.129 99.900 0.138
202012 0.262 99.300 0.282
202103 0.216 99.900 0.231
202106 0.184 99.500 0.197
202109 0.223 100.100 0.238
202112 0.177 100.100 0.189
202203 0.107 101.100 0.113
202206 0.214 101.800 0.225
202209 0.037 103.100 0.038
202212 0.029 104.100 0.030
202303 0.000 104.400 0.000
202306 0.000 105.200 0.000
202309 0.000 106.200 0.000
202312 0.000 106.800 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nipro  (OTCPK:NPRRF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nipro Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nipro's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (NPRRF) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines